• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型人类免疫缺陷病毒感染者中辅助受体使用导致的炎症和免疫激活模式

Patterns of inflammation and immune activation by coreceptor use in people living with HIV-1.

作者信息

Guerra-Castillo Francisco Xavier, Pinto-Cardoso Sandra, Ávila-Ríos Santiago, Chávez-Torres Monserrat, Peralta-Prado Amy, González-Torres Carolina, Gaytán-Cervantes Javier, Requena-Benitez Brenda, Díaz-Rivera Dafne, Alaez-Verson Carmen, Hernández-García María Concepción, Bekker-Méndez Vilma Carolina

机构信息

Unidad de Investigación Médica en Inmunología e Infectología, Hospital de Infectología "Dr. Daniel Méndez Hernández", Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.

Posgrado en Ciencias Biológicas, Unidad de Posgrado, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, Mexico.

出版信息

Front Immunol. 2025 Jul 10;16:1632287. doi: 10.3389/fimmu.2025.1632287. eCollection 2025.

DOI:10.3389/fimmu.2025.1632287
PMID:40709192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12286835/
Abstract

INTRODUCTION

Human immunodeficiency virus type 1 (HIV-1) utilizes either the CCR5 (R5) or CXCR4 (X4) coreceptor for host cell entry. Coreceptor switching from R5 to X4 and elevated immune activation have been associated with disease progression. X4-tropic HIV-1 is predominantly observed in the late stage of infection, when the immune environment characterized by chronic activation is optimal for their replication. The aim of this study was to determine viral tropism in late HIV presenters and who have not previously received treatment in Mexico City and its relationship with markers of chronic immune activation.

METHODS

A cross-sectional study was conducted on 122 people living with HIV (PLWH) recruited from two public health services. Viral tropism was determined using next-generation sequencing (NGS) and the geno2pheno algorithm. Immune activation was assessed through flow cytometry (CD38+, HLA-DR+), and soluble markers (sCD14, sCD163, IL-6) were quantified using enzyme-linked immunosorbent assays (ELISA). Differences in immune activation patterns between R5 and X4 group were explored using Mann-Whitney Wilcoxon test and t-test, and a principal component analysis (PCA). Logistic regression was used to evaluate associations between immune activation profiles and the presence of X4-tropic viruses.

RESULTS

Ninety-eight individuals had high-quality V3 loop sequences, 81.6% harbored only R5 variants (R5 group), while 18.4% had mixed R5/X4 populations (X4 group). Most PLWH had CD4+ T cell counts below 200 cells/µL, showing no significant difference between groups. Elevated levels of IL-6 were significantly associated with the R5 group (p = 0.01), while the X4 group showed increased expression of CD38+ and HLA-DR+CD38+ markers, although not statistically significant. Furthermore, IL-6 emerges as a negative predictor for the presence of X4 viruses (OR = 0.06, p = 0.006).

CONCLUSION

R5-tropic viruses are associated with elevated inflammatory responses in early stages, as indicated by higher IL-6 levels, while X4-tropic viruses may contribute to CD4+ T cell depletion through immune activation. Consequently, elevated levels of IL-6 emerge as a negative predictor for the presence of X4 viruses. The relationship between viral tropism and chronic immune activation in HIV-1 infection reflects a complex interplay which appears to be bidirectional.

摘要

引言

1型人类免疫缺陷病毒(HIV-1)利用CCR5(R5)或CXCR4(X4)共受体进入宿主细胞。共受体从R5向X4的转换以及免疫激活增强与疾病进展相关。X4嗜性HIV-1主要在感染后期出现,此时以慢性激活为特征的免疫环境最适合其复制。本研究的目的是确定墨西哥城未接受过治疗的晚期HIV感染者的病毒嗜性及其与慢性免疫激活标志物的关系。

方法

对从两个公共卫生服务机构招募的122名HIV感染者(PLWH)进行了一项横断面研究。使用下一代测序(NGS)和geno2pheno算法确定病毒嗜性。通过流式细胞术(CD38+、HLA-DR+)评估免疫激活,并使用酶联免疫吸附测定(ELISA)对可溶性标志物(sCD14、sCD163、IL-6)进行定量。使用Mann-Whitney Wilcoxon检验和t检验以及主成分分析(PCA)探讨R5和X4组之间免疫激活模式的差异。使用逻辑回归评估免疫激活谱与X4嗜性病毒存在之间的关联。

结果

98名个体具有高质量的V3环序列,81.6%仅携带R5变体(R5组),而18.4%具有R5/X4混合群体(X4组)。大多数PLWH的CD4+T细胞计数低于200个细胞/µL,两组之间无显著差异。IL-6水平升高与R5组显著相关(p = 0.01),而X4组的CD38+和HLA-DR+CD38+标志物表达增加,尽管无统计学意义。此外,IL-6是X4病毒存在的负预测因子(OR = 0.06,p = 0.006)。

结论

如较高的IL-6水平所示,R5嗜性病毒与早期炎症反应增强相关,而X4嗜性病毒可能通过免疫激活导致CD4+T细胞耗竭。因此,IL-6水平升高是X4病毒存在的负预测因子。HIV-1感染中病毒嗜性与慢性免疫激活之间的关系反映了一种似乎是双向的复杂相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/12286835/1330831016b7/fimmu-16-1632287-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/12286835/a039725a9bb0/fimmu-16-1632287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/12286835/beb1b3d6823b/fimmu-16-1632287-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/12286835/9af484796276/fimmu-16-1632287-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/12286835/1330831016b7/fimmu-16-1632287-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/12286835/a039725a9bb0/fimmu-16-1632287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/12286835/beb1b3d6823b/fimmu-16-1632287-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/12286835/9af484796276/fimmu-16-1632287-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/12286835/1330831016b7/fimmu-16-1632287-g004.jpg

相似文献

1
Patterns of inflammation and immune activation by coreceptor use in people living with HIV-1.1型人类免疫缺陷病毒感染者中辅助受体使用导致的炎症和免疫激活模式
Front Immunol. 2025 Jul 10;16:1632287. doi: 10.3389/fimmu.2025.1632287. eCollection 2025.
2
Covariation of Amino Acid Substitutions in the HIV-1 Envelope Glycoprotein gp120 and the Antisense Protein ASP Associated with Coreceptor Usage.HIV-1包膜糖蛋白gp120中氨基酸取代与核心受体使用相关的反义蛋白ASP的共变
Viruses. 2025 Feb 26;17(3):323. doi: 10.3390/v17030323.
3
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
4
Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.HIV-1 感染者血浆中存在具有不同核心受体使用偏好的复制型次要变异体。
J Virol. 2020 Jun 1;94(12). doi: 10.1128/JVI.00193-20.
5
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.在感染过程中,开关(R5 到 R5X4/X4-嗜性)和非开关(仅 R5-嗜性)HIV-1 群体之间的分子进化差异。
Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Antiretroviral therapy initiated during acute infection in women with HIV-1 clade C reduces anti-Tat antibody production and lowers CD8+ T cell activation.在感染HIV-1 C亚型的女性急性感染期开始抗逆转录病毒治疗,可减少抗Tat抗体产生并降低CD8+ T细胞活化。
Front Immunol. 2025 Jun 18;16:1564960. doi: 10.3389/fimmu.2025.1564960. eCollection 2025.

本文引用的文献

1
Evolution Driven By A Varying Host Environment Selects For Distinct HIV-1 Entry Phenotypes and Other Informative Variants.由不断变化的宿主环境驱动的进化选择了不同的HIV-1进入表型和其他信息性变体。
Front Virol. 2023;3. doi: 10.3389/fviro.2023.1291996. Epub 2023 Nov 16.
2
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia.血浆人类免疫缺陷病毒 1 可溶性糖蛋白 120 与抗病毒治疗后病毒血症不可检测个体免疫功能障碍和炎症相关因素的关联。
J Infect Dis. 2024 Mar 14;229(3):763-774. doi: 10.1093/infdis/jiad503.
3
PCAtest: testing the statistical significance of Principal Component Analysis in R.
PCAtest:在 R 中检验主成分分析的统计显著性。
PeerJ. 2022 Feb 17;10:e12967. doi: 10.7717/peerj.12967. eCollection 2022.
4
The role of CD38 in HIV infection.CD38 在 HIV 感染中的作用。
AIDS Res Ther. 2021 Apr 5;18(1):11. doi: 10.1186/s12981-021-00330-6.
5
Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection.免疫激活与 HIV-1 感染中 CXCR4 共受体嗜性转换相关,并可预测该转换。
Sci Rep. 2020 Sep 28;10(1):15866. doi: 10.1038/s41598-020-71699-z.
6
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping.多实验室比较下一代测序与基于 Sanger 的测序在 HIV-1 耐药性基因分型中的应用。
Viruses. 2020 Jun 27;12(7):694. doi: 10.3390/v12070694.
7
'Rinse and Replace': Boosting T Cell Turnover To Reduce HIV-1 Reservoirs.冲洗并替换:提高 T 细胞周转率以减少 HIV-1 储存库。
Trends Immunol. 2020 Jun;41(6):466-480. doi: 10.1016/j.it.2020.04.003. Epub 2020 May 12.
8
CD4CD38 central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART.CD4CD38 中央记忆性 T 细胞在接受长期抗逆转录病毒治疗的 HIV 感染者中促成 HIV 的持续存在。
J Transl Med. 2020 Feb 24;18(1):95. doi: 10.1186/s12967-020-02245-8.
9
Maintenance of Functional CD57+ Cytolytic CD4+ T Cells in HIV+ Elite Controllers.HIV 精英控制者中功能性 CD57+细胞毒性 CD4+T 细胞的维持。
Front Immunol. 2019 Aug 8;10:1844. doi: 10.3389/fimmu.2019.01844. eCollection 2019.
10
Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.支持基于下一代测序的 HIV 耐药性检测的生物信息学数据处理管道:温尼伯共识。
J Int AIDS Soc. 2018 Oct;21(10):e25193. doi: 10.1002/jia2.25193.